M-Vax: Phase I/II data

In a double-blind, U.S. Phase I/II trial in 56 patients, 22 of 29 patients receiving the high dose of M-Vax had a positive DTH response vs. baseline. Patients received M-Vax doses of 5x10 6 cells (hig...